Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Mai Abdelmageed, B.Pharm, MSc, PhD
PhD Student
University of Florida
Poster(s):
093: Trends in First-in-Human Trials of Intrathecal Antisense Oligonucleotide Therapies: Insights into Dose Selection, Dose Escalation & Early Clinical Development
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
094: Analyzing First-in-Human Trial Designs of Antisense Oligonucleotides: A Preliminary Review Across Subcutaneous, Intravenous & Intrathecal Routes of Administration
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
